货币 / ABVX
ABVX: Abivax SA - American Depositary Shares
68.60
USD
5.71
(9.08%)
今日ABVX汇率已更改9.08%。当日,交易品种以低点62.51和高点71.35进行交易。
关注Abivax SA - American Depositary Shares动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ABVX新闻
- TipRanks Why Is Abivax Stock (ABVX) Up 490% Today? - TipRanks.com
- Investing U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.14%
- Investing Abivax launches $400 million public offering of American depositary shares
- Seeking Alpha Abivax: Differentiated Phase 3 Data Ignites A Multi-Billion Dollar Opportunity
- Benzinga Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views - Abivax (NASDAQ:ABVX), Alpha Modus Holdings (NASDAQ:AMOD)
- Investing Piper Sandler raises Abivax stock price target to $70 on positive UC trial data
- Benzinga GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma (NASDAQ:ARWR), Abivax (NASDAQ:ABVX)
- Benzinga Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings - Abivax (NASDAQ:ABVX), Alpha Modus Holdings (NASDAQ:AMOD)
- Investing Morgan Stanley upgrades Abivax stock to Overweight on strong ulcerative colitis data
- Investor's Business Daily Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results
- Investing Abivax stock price target raised to $74 from $20 at Leerink on strong UC data
- Benzinga Why Abivax Stock Is Skyrocketing Wednesday - Abivax (NASDAQ:ABVX)
- Investing Abivax’s ulcerative colitis drug meets primary goals in Phase 3 trials; shares jump 400%
- Investing Abivax stock price target raised to $101 from $50 at Guggenheim after positive trial data
- Benzinga Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Abivax (NASDAQ:ABVX)
- Investing Abivax stock price target raised to $95 from $33 at JMP on strong trial data
- Investing US-listed Abivax shares skyrocket on positive phase 3 data for colitis drug
- Investing Abivax reports positive phase 3 results for ulcerative colitis drug
- Seeking Alpha Abivax Stock: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout (ABVX)
- Investing Abivax stock rating reiterated at Market Outperform by Citizens JMP
- Investing Citizens JMP reiterates Market Outperform rating on Abivax stock
- Investing Piper Sandler reiterates Overweight rating on Abivax stock ahead of UC data
- Investing Abivax Announces Results of its June 6, 2025 Annual General Meeting
- Seeking Alpha ABIVAX: Undercovered, Late-Stage French Company With Upcoming Catalysts (NASDAQ:ABVX)
日范围
62.51
71.35
年范围
4.77
71.35
- 前一天收盘价
- 10.00
- 开盘价
- 62.89
- 卖价
- 68.60
- 买价
- 68.90
- 最低价
- 62.51
- 最高价
- 71.35
- 交易量
- 44.638 K
- 日变化
- 9.08%
- 月变化
- 776.12%
- 6个月变化
- 1076.67%
- 年变化
- 481.36%
24 七月, 星期四
12:30
USD
- 实际值
- 预测值
- -0.12
- 前值
- -0.28
12:30
USD
- 实际值
- 预测值
- 215 K
- 前值
- 221 K
12:30
USD
- 实际值
- 预测值
- 1.972 M
- 前值
- 1.956 M
12:30
USD
- 实际值
- 预测值
- 225.813 K
- 前值
- 229.500 K
14:00
USD
- 实际值
- 预测值
- 0.684 M
- 前值
- 0.623 M
14:00
USD
- 实际值
- 预测值
- -3.2%
- 前值
- -13.7%
14:30
USD
- 实际值
- 预测值
- 20 B
- 前值
- 46 B
15:00
USD
- 实际值
- 预测值
- -2
- 前值
- -2
15:00
USD
- 实际值
- 预测值
- -5
- 前值
- 5
15:30
USD
- 实际值
- 预测值
- 前值
- 4.230%
15:30
USD
- 实际值
- 预测值
- 前值
- 4.270%
17:00
USD
- 实际值
- 预测值
- 前值
- 2.220%